Profiel
Andrew R.
Miksztal worked as an Associate Director-Pharmaceutical Analysis at Oread Laboratories, Inc. from 1996 to 2000.
Prior to that, he worked as a Scientist-Preformulation & Pharmaceutical Analysis at Syntex Corp.
from 1987 to 1995.
He also worked as a Senior Scientist-Pharmaceutical Research at Roche Palo Alto LLC in 1995 and 1996.
Dr. Miksztal earned a doctorate degree from Rutgers State University of New Jersey.
Eerdere bekende functies van Andrew R. Miksztal
| Bedrijven | Functie | Einde |
|---|---|---|
| Oread Laboratories, Inc. | Corporate Officer/Principal | 01-01-2000 |
Roche Palo Alto LLC
 Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Chief Tech/Sci/R&D Officer | 01-01-1996 |
| Syntex Corp. | Chief Tech/Sci/R&D Officer | 01-01-1995 |
Opleiding van Andrew R. Miksztal
| Rutgers State University of New Jersey | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
| Syntex Corp. | Health Technology |
Roche Palo Alto LLC
Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Health Technology |
| Oread Laboratories, Inc. |
